C14H17ClN2O4
312.75 g/mol
Pharmaceutical IntermediateDanger
4-chloro-6,7-bis(2-methoxyethoxy)quinazoline
CAS183322-18-1EC605-994-5
Category
Pharmaceutical Intermediate
Compound Class
Heterocycle
Primary Use
Pharmaceutical Intermediate
4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline is a chlorinated quinazoline derivative used as a pharmaceutical intermediate. Its primary significance lies in its role as a key building block in the synthesis of the anticancer agent erlotinib.
Pharmaceutical intermediate for erlotinib synthesis
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 183322-18-1
Related Compounds
ReferenceSame Category
4-Chloro-6,7-bis(2-chloroethoxy)quinazoline
CAS183322-21-6
pharmaceutical intermediate
ReferenceSame Category
(2S,3S,5S)-5-tert-Butyloxycarbonylamino-2-amino-3-hydroxy-1,6-diphenylhexane succinate
CAS183388-64-9
pharmaceutical intermediate
ReferenceSame Category
4,6-diamino-2-chloropyrimidine-5-carbonitrile
CAS18340-56-2
pharmaceutical intermediate
ReferenceSame Category
2-Amino-5-cyano-3-methylpyridine
CAS183428-91-3
pharmaceutical intermediate
Safety Reference
Danger
H302Harmful if swallowed
H318Causes serious eye damage
Identifiers
IUPAC Name
4-chloro-6,7-bis(2-methoxyethoxy)quinazoline
InChIKey
ZPJLDMNVDPGZIU-UHFFFAOYSA-N
SMILES
COCCOC1=C(C=C2C(=C1)C(=NC=N2)Cl)OCCOC
Synonyms (9)
- CP-335963, >=98% (HPLC)
- Erlotinib HCL Intermediate 2